Clinical Trial Update: Evaluation of GM101 Injection in Patients With Parkinson's Disease [EARLY_Phase 1]

View source ↗

Summary

Genemagic Biosciences is conducting an early Phase 1 trial of GM101 injection for Parkinson's disease, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• GM101 injection

Snippet

Sponsor: Genemagic Biosciences Co., Ltd | Conditions: Parkinson's Disease | EARLY_Phase 1 | Status: RECRUITING